Leishmaniasis in Sudan 1. Cutaneous leishmaniasis

被引:28
作者
El-Hassan, AM
Zijlstra, EE
机构
[1] Univ Khartoum, Inst Endem Dis, Dept Immunol & Clin Pathol, Khartoum, Sudan
[2] Univ Khartoum, Inst Endem Dis, Dept Epidemiol & Clin Sci, Khartoum, Sudan
关键词
leishmaniasis; cutaneous leishmaniasis; Leishmania major; Phlebotomus papatasi; clinical features; diagnosis; epidemiology; history; pathology; treatment; Sudan;
D O I
10.1016/S0035-9203(01)90216-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cutaneous leishmaniasis (CL) in Sudan is caused by Leishmania major, zymodeme LON-1. The disease is endemic in many parts of the country. The vector is Phlebotomus papatasi and the animal reservoir is probably the Nile rat Arvicanthis niloticus. Clinically, patients usually present with papules, nodules, or noduloulcerative lesions, mainly on the exposed parts of the skin. In 20% of cases the parasite disseminates through the lymphatics, producing sporotrichoid-like lesions. The pathology of the lesion is described. Langerhans cells are the main antigen-presenting cells in CL. They pick up antigen from the dermis and migrate to regional lymph nodes where they present it to T cells. Antigen-specific activated T cells home to the dermis where they stimulate macrophages to eliminate the parasite. Peripheral blood mononuclear cells (PBMC) proliferate in response to Leishmania antigen in vitro and produce cytokines. PBMC of patients with mild and severe disease produce Th-1- and Th-2- like cytokine patterns, respectively. The criteria for the clinical diagnosis of CL are described. The diagnosis is confirmed by the demonstration of parasites in slit smears in 50-70% of cases and in histological sections in 70%. With primers specific for L. major, the polymerase chain reaction is positive in 86% of cases. Since CL is a self-limiting disease, treatment is confined to patients with severe disease.
引用
收藏
页码:S1 / S17
页数:17
相关论文
共 73 条
[1]   EPIDEMIC OF CUTANEOUS LEISHMANIASIS IN NORTHERN SUDAN [J].
ABDALLA, RE ;
SHERIF, H .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1978, 72 (04) :349-352
[2]   CUTANEOUS LEISHMANIASIS IN SUDAN [J].
ABDALLA, RE ;
ALI, M ;
WASFI, AI ;
ELHASSAN, AM .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1973, 67 (04) :549-559
[3]   DISSEMINATION IN CUTANEOUS LEISHMANIASIS .3. LYMPH-NODE INVOLVEMENT [J].
ALGINDAN, Y ;
KUBBA, R ;
ELHASSAN, AM ;
OMER, AHS ;
KUTTY, MK ;
SAEED, MBM .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1989, 28 (04) :248-254
[4]   CRYOSURGERY IN OLD-WORLD CUTANEOUS LEISHMANIASIS [J].
ALGINDAN, Y ;
KUBBA, R ;
OMER, AHS ;
ELHASSAN, AM .
BRITISH JOURNAL OF DERMATOLOGY, 1988, 118 (06) :851-854
[5]   Evaluation of the polymerase chain reaction in the diagnosis of cutaneous leishmaniasis due to Leishmania major: A comparison with direct microscopy of smears and sections from lesions [J].
Andresen, K ;
Gaafar, A ;
ElHassan, AM ;
Ismail, A ;
Dafalla, M ;
Theander, TG ;
Kharazmi, A .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (02) :133-135
[6]  
ARCHIBALD RG, 1911, 4TH REP WELLC TROP R, P207
[7]  
BADI M, 1990, THESIS U KHARTOUM
[8]   Terbinafine in the treatment of cutaneous leishmaniasis: A pilot study [J].
Bahamdan, KA ;
Tallab, TM ;
Johargi, H ;
Nourad, MM ;
Ibrahim, K ;
ElSherbini, AH ;
Karkashan, E ;
Khare, AK ;
Nauri, MM .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1997, 36 (01) :59-60
[9]   CRYOSURGERY IN CUTANEOUS LEISHMANIASIS [J].
BASSIOUNY, A ;
ELMESHAD, M ;
TALAAT, M ;
KUTTY, K ;
METAWAA, B .
BRITISH JOURNAL OF DERMATOLOGY, 1982, 107 (04) :467-474
[10]  
BIENZLE U, 1978, TROPENMED PARASITOL, V29, P188